IMS
JAZZ icon

Index Management Solutions’s Jazz Pharmaceuticals JAZZ Stock Holding History

Index Management Solutions’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$29K Sell
222
-3
-1% -$517 0.03% 330
2015
Q2 		$40K Buy
225
+126
+127% +$22.6K 0.04% 314
2015
Q1 		$17K Buy
+99
New +$17K 0.01% 426

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Index Management Solutions's JAZZ Position: Q3 2015 in Review

Index Management Solutions reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.3% in Q3 2015, selling an estimated $517 and leaving 222 shares worth $29K. The position accounts for 0.03% of the portfolio, ranked #330.

Index Management Solutions first reported a position in JAZZ in Q1 2015 and has held it in 3 quarters since. The position peaked at $40K in Q2 2015. 360 funds tracked by Wall St. Rank hold JAZZ as of Q3 2015.

  • Index Management Solutions held 222 shares of Jazz Pharmaceuticals worth $29K as of Q3 2015.
  • Index Management Solutions sold 3 Jazz Pharmaceuticals shares in Q3 2015, an estimated $517.
  • Jazz Pharmaceuticals made up 0.03% of Index Management Solutions's portfolio in Q3 2015, its #330 holding.
  • Index Management Solutions first reported a position in Jazz Pharmaceuticals in Q1 2015 and has held it in 3 quarters since.
  • Index Management Solutions's Jazz Pharmaceuticals position peaked at $40K in Q2 2015.
  • 360 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2015.

Based on Index Management Solutions's 13F filing for Q3 2015, filed 13 Nov 2015.